SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024178
Filing Date
2022-11-10
Accepted
2022-11-10 08:05:46
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q inab-20220930.htm   iXBRL 10-Q 2534437
2 EX-31.1 inab-ex31_1.htm EX-31.1 24232
3 EX-31.2 inab-ex31_2.htm EX-31.2 23704
4 EX-32.1 inab-ex32_1.htm EX-32.1 23954
5 GRAPHIC img237943307_0.jpg GRAPHIC 66213
  Complete submission text file 0000950170-22-024178.txt   7688861

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inab-20220930.xsd EX-101.SCH 45512
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inab-20220930_pre.xml EX-101.PRE 292617
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inab-20220930_lab.xml EX-101.LAB 390546
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inab-20220930_cal.xml EX-101.CAL 40869
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inab-20220930_def.xml EX-101.DEF 132012
55 EXTRACTED XBRL INSTANCE DOCUMENT inab-20220930_htm.xml XML 1187374
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39692 | Film No.: 221375053
SIC: 2836 Biological Products, (No Diagnostic Substances)